Literature DB >> 9720856

Longitudinal changes associated with improvement in chronic fatigue patients.

J Russo1, W Katon, M Clark, P Kith, M Sintay, D Buchwald.   

Abstract

Tertiary care patients with chronic fatigue were followed for 2.5 years to determine if changes in physical and psychological status were associated with improvements in chronic fatigue, physical functioning, and return to work. Results indicated that improvement in psychological symptoms, DSM-III-R disorders, physical examination signs, and changes in whether the patient continued to meet criteria for chronic fatigue syndrome (CFS) were associated with recovery from fatigue, improved functioning, and return to work. Patients who never met CFS criteria or only met criteria at the initial assessment, reported improved physical functioning. Patients whose psychiatric disorders and physical examination signs were still present at a mean follow-up time of 2.5 years were more likely to have persistent fatigue and work disability. Loss of physical examination signs was a significant independent predictor of improved functioning and return to work. These results suggest that psychiatric status, as well as physical status, are associated with recovery from chronic fatigue.

Entities:  

Mesh:

Year:  1998        PMID: 9720856     DOI: 10.1016/s0022-3999(97)00297-3

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  3 in total

Review 1.  Defining recovery in chronic fatigue syndrome: a critical review.

Authors:  Jenna L Adamowicz; Indre Caikauskaite; Fred Friedberg
Journal:  Qual Life Res       Date:  2014-05-03       Impact factor: 4.147

Review 2.  Chronic fatigue syndrome: an update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

3.  Prognosis of fatigue and functioning in primary care: a 1-year follow-up study.

Authors:  Iris Nijrolder; Daniëlle A W M van der Windt; Henriëtte E van der Horst
Journal:  Ann Fam Med       Date:  2008 Nov-Dec       Impact factor: 5.166

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.